Barton Investment Management’s GSK GSK Stock Holding History

Barton Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,626	Closed	-$213K	–	41
2019 Q4	$213K	Buy	+3,626	New	+$202K	0.03%	41
2016 Q1	–	Sell	-3,626	Closed	-$183K	–	69
2015 Q4	$183K	Buy	+3,626	New	+$185K	0.06%	45
2015 Q2	–	Sell	-3,626	Closed	-$209K	–	46
2015 Q1	$209K	Buy	+3,626	New	+$208K	0.08%	44
2014 Q4	–	Sell	-3,626	Closed	-$208K	–	45
2014 Q3	$208K	Hold	3,626	–	–	0.08%	45
2014 Q2	$242K	Hold	3,626	–	–	0.09%	44
2014 Q1	$242K	Hold	3,626	–	–	0.1%	44
2013 Q4	$242K	Sell	3,626 -400	-10%	-$25.9K	0.1%	47
2013 Q3	$253K	Hold	4,026	–	–	0.11%	45
2013 Q2	$251K	Buy	+4,026	New	+$256K	0.13%	47

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Barton Investment Management's GSK Position: Q1 2020 in Review

Barton Investment Management sold out of GSK (GSK) in Q1 2020, closing a stake of 3,626 shares — an estimated $213K sold.

Barton Investment Management first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $253K in Q3 2013. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Barton Investment Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Barton Investment Management sold 3,626 GSK shares in Q1 2020, an estimated $213K.
Barton Investment Management first reported a position in GSK in Q2 2013 and held it in 9 quarters.
Barton Investment Management's GSK position peaked at $253K in Q3 2013.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Barton Investment Management's 13F filing for Q1 2020, filed 30 Apr 2020.